PREDICTORS OF G-CSF PROPHYLAXIS IN THE FIRST CYCLE OF CHEMOTHERAPY FOR FEBRILE NEUTROPENIA IN PATIENTS WITH NON-HODGKIN'S LYMPHOMA

被引：0
|
作者：
Lugtenburg, P. [1 ]
Asubonteng, J. [2 ]
DeCosta, L. [3 ]
Szabo, Z. [4 ]
Page, J. H. [5 ]
Wetten, S. [3 ]
机构：
[1] Erasmus Mc Canc Inst, Rotterdam, Netherlands
[2] Univ Pittsburgh, Pittsburgh, PA USA
[3] Amgen Ltd, London, England
[4] Amgen Inc, Zug, Switzerland
[5] Amgen Inc, Thousand Oaks, CA USA
来源：
HAEMATOLOGICA | 2014年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P583
引用
收藏
页码：196 / 196
页数：1
相关论文
共 50 条
  • [41] Reversible renal impairment during leukocytosis induced by G-CSF in non-Hodgkin's lymphoma
    Hirokawa, M
    Lee, M
    Motegi, M
    Miura, AB
    AMERICAN JOURNAL OF HEMATOLOGY, 1996, 51 (04) : 328 - 329
  • [42] GX-G3, a long-acting G-CSF, compared with pegfilgrastim in reducing duration of severe neutropenia after chemotherapy for non-Hodgkin's lymphoma.
    Ertan-Ahmed, Senem
    Kiehl, Michael G.
    Radinoff, Atanas
    Graklanov, Vasko
    Tzvetkov, Nikolay
    Mihaescu, Rodica
    Ozatli, Duzgun
    Atalay, Figen
    Turgut, Burhan
    Cho, Seok-Gu
    Rekhtman, Grygoriy
    Sahin, Adem
    Oncel, Hatice
    Choi, Yuri
    Yang, Sang-In
    Choi, Yoon-Jeong
    Heo, MinKyu
    Sung, Young Chul
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [43] FDG uptake in bone marrow after G-CSF administration in patients with non-Hodgkin lymphoma
    Hanaoka, K.
    Hosono, M.
    Komeya, Y.
    Tsuchiya, N.
    Usami, K.
    Yamazoe, Y.
    Ishii, K.
    Tatsumi, Y.
    Murakami, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S433 - S433
  • [44] A randomized study of interventional G-CSF therapy in patients with febrile neutropenia following chemotherapy
    Mitchell, PLR
    Morland, BJ
    Dick, G
    Easlea, D
    Bliss, J
    Meyer, LC
    Stevens, MCG
    Pinkerton, CR
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 229 - 229
  • [45] Medicare Claim Processors' Reimbursement and G-CSF Choice Among Non-Hodgkin Lymphoma Patients
    Pan, Xiaoyun
    Sambamoorthi, Usha
    AMERICAN JOURNAL OF PHARMACY BENEFITS, 2013, 5 (04) : 147 - 154
  • [46] FDG uptake in bone marrow after G-CSF administration in patients with non-Hodgkin lymphoma
    Hanaoka, Kohei
    Hosono, Makoto
    Komeya, Yoshihiro
    Tsuchiya, Norio
    Ohata, Akiko
    Usami, Kimio
    Yamazoe, Yuzuru
    Sumita, Mitsugu
    Ito, Tetsuo
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [47] ECONOMIC COSTS OF CHEMOTHERAPY-INDUCED FEBRILE NEUTROPENIA AMONG PATIENTS WITH NON-HODGKIN'S LYMPHOMA IN EUROPEAN CLINICAL PRACTICE
    Weycker, D.
    Danel, A.
    Marciniak, A.
    Bendall, K.
    Lipsitz, M.
    Pettengell, R.
    VALUE IN HEALTH, 2011, 14 (07) : A413 - A413
  • [48] Pegfilgrastim in primary prophylaxis of febrile neutropenia in elderly patients with hematological malignanciesbendamustine and G-CSF support
    Cerchione, Claudio
    De Renzo, Amalia
    Nappi, Davide
    Di Perna, Maria
    Della Pepa, Roberta
    Pugliese, Novella
    Catalano, Lucio
    Pane, Fabrizio
    Picardi, Marco
    SUPPORTIVE CARE IN CANCER, 2019, 27 (05) : 1587 - 1588
  • [49] Use Of Pegfilgrastim Primary Prophylaxis By Chemotherapy Cycle Among Patients With Non-Hodgkin's Lymphoma Or Breast Cancer
    Langeberg, Wendy J.
    Siozon, Conchitina C.
    Morrow, P. K.
    Page, John H.
    Chia, Victoria M.
    BLOOD, 2013, 122 (21)
  • [50] A STUDY OF RHTPO IN COMBINATION WITH CHEMOTHERAPY AND G-CSF FOR PERIPHERAL BLOOD PROGENITOR CELL MOBILIZATION IN PATIENTS WITH RELAPSED NON-HODGKIN LYMPHOMA
    Bai, H.
    Zhu, J.
    Wang, C.
    Hao, S.
    Hu, J.
    Zou, S.
    HAEMATOLOGICA, 2016, 101 : 285 - 286
12345